Atrys Health (XMAD:ATRY) Tax Rate %: 1.66% (As of Dec. 2025)

What is Atrys Health Tax Rate %?

Atrys Health XMAD:ATRY -0.39% 66 Tax Rate % is 1.66% as of Dec. 2025. GuruFocus rates XMAD:ATRY with a GF Score™ of 66/100 and a GF Value™ of €3.13 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Atrys Health's Tax Expense for the six months ended in Dec. 2025 was €-0.7 Mil. Atrys Health's Pre-Tax Income for the six months ended in Dec. 2025 was €-42.7 Mil. Therefore, Atrys Health's Tax Rate % for the quarter that ended in Dec. 2025 was 1.66%.

Atrys Health Tax Rate % Related Terms

Atrys Health Tax Rate % Historical Data

* Premium members only.

The historical data trend for Atrys Health's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atrys Health Tax Rate % Chart

Atrys Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Tax Rate %

Get a 7-Day Free Trial

6.77

3.13

8.73

5.36

1.02

Atrys Health Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Tax Rate %	Get a 7-Day Free Trial															-4.31	5.02	10.25	3.39	1.66

66GF Score

Atrys Health SA XMAD:ATRY

Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Atrys Health Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Atrys Health's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2025 )	/	Pre-Tax Income (A: Dec. 2025 )
	=	-0.576	/	-56.201
	=	1.02 %

Atrys Health's Tax Rate % for the quarter that ended in Dec. 2025 is calculated as

Tax Rate %	=	Tax Expense (Q: Dec. 2025 )	/	Pre-Tax Income (Q: Dec. 2025 )
	=	-0.707	/	-42.694
	=	1.66 %

Frequently Asked Questions Learn more about Tax Rate % →

What does a Tax Rate % of 1.66% mean?

Atrys Health (XMAD:ATRY) has a Tax Rate % of 1.66% as of Dec. 2025.

Is Atrys Health's Tax Rate % too high?

Atrys Health's current Tax Rate % is 1.66%. Overall, Atrys Health has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Atrys Health's Tax Rate % compare to VRTX and REGN?

Atrys Health's Tax Rate % of 1.66% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Tax Rate % for a Biotechnology company?

A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Tax Rate % mean?

A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Atrys Health's current Tax Rate % is 1.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Atrys Health stock overvalued right now?

Based on GuruFocus' analysis, Atrys Health (XMAD:ATRY) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.13, compared to a current price of €2.52 — trading 19.5% below its estimated fair value. The current Tax Rate % is 1.66%. Atrys Health's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Tax Rate % calculated?

Tax Rate % is calculated from a company's financial statements. For Atrys Health (XMAD:ATRY), the current Tax Rate % is 1.66% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atrys Health (XMAD:ATRY) Overvalued in 2026?

Based on GuruFocus' analysis, Atrys Health stock appears to be undervalued. The current stock price of €2.52 is trading 19.5% below its estimated GF Value™ of €3.13. GuruFocus considers Atrys Health to be Modestly Undervalued.

Key valuation signals for XMAD:ATRY:

Tax Rate %: 1.66%
GF Value™: €3.13 vs. price of €2.52 (19.5% below fair value)
GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the XMAD:ATRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Atrys Health Business Description

Industry Healthcare Biotechnology

Comparable Companies XMAD:ORY XMAD:VYT XMAD:BST VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA XKRX:068270 RPRX ROIV BNTX INCY INSM HKSE:02269

Other Exchanges A2T:Germany

Address Calle Provenca, 392 planta baja, Barcelona, ESP, 08025

Website https://www.atryshealth.com

Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

66GF Score

Get the complete analysis for XMAD:ATRY

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.52

Price

€3.13

GF Value

View XMAD:ATRY Analysis

See Tax Rate % data for all stocks →